CIK 0001001316
- Large accelerated filer
TG THERAPEUTICS, INC.
Sign in to watch- Ticker
- TGTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 363898269
- Phone
- +1 212-554-4484
- Business address
- 2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY, 10014
- Former names
- MANHATTAN PHARMACEUTICALS INC, ATLANTIC TECHNOLOGY VENTURES INC, ATLANTIC PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $274,800
- in 1 filing
Net −$274,800. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2010-03-03 | ABEL DOUGLAS Director | Grant or award · Stock Options | +50,000 | 50,000 | ||
| 2008-09-11 | ABEL DOUGLAS President and CEO | Grant or award · Warrant | +24,000 | 24,000 | ||
| 2008-03-25 | ABEL DOUGLAS President and CEO | Grant or award · Stock Options | +1,300,000 | 1,300,000 | ||
| 2007-08-01 | ABEL DOUGLAS Chief Executive Officer | Grant or award | +10,000 | $0.27 | $3K | 45,000 |
| 2007-07-20 | ABEL DOUGLAS President and CEO | Grant or award | +10,000 | $0.36 | $4K | 45,000 |
| 2007-07-13 | ABEL DOUGLAS President and CEO | Grant or award | +5,000 | $0.34 | $2K | 35,000 |
| 2007-04-25 | ABEL DOUGLAS President and CEO | Grant or award · Stock Options | +250,000 | 250,000 |
Page 1 of 1 · 7 trades